BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21696506)

  • 1. Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor.
    Ueno K; Nomura Y; Arata M; Maruyama S; Tanabe T; Eguchi T; Kawano Y
    Pediatr Int; 2011 Jun; 53(3):388-90. PubMed ID: 21696506
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission of autoimmune neutropenia after development of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Ichimura T; Kaneyasu H; Shimomura M; Wakabayashi-Takahara M; Nakamura K; Kobayashi M; Ohga S
    Pediatr Int; 2015 Oct; 57(5):1012-4. PubMed ID: 26508185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
    Akilov OE; Desai N; Jaffe R; Gehris RP
    Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label use of granulocyte colony-stimulating factor in noncongenital neutropenia: retrospective data from the Italian Neutropenia Registry.
    Fioredda F; Calvillo M; Renga D; Bonanomi S; Ciliberti A; Martire B; Ghilardi R; Dufour C
    Pediatr Hematol Oncol; 2008 Jun; 25(4):371-4. PubMed ID: 18484485
    [No Abstract]   [Full Text] [Related]  

  • 5. Different responses to granulocyte colony-stimulating factor treatment in siblings with alloimmune neonatal neutropenia.
    Latini G; Del Vecchio A; Rosati E; Borzini P; Chirico G; Rondini G
    Acta Paediatr; 1999 Dec; 88(12):1407-9. PubMed ID: 10626532
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of granulocyte colony-stimulating factor to correct neutropenia in chronic lymphocytic leukaemia.
    Vickers M
    Clin Lab Haematol; 1997 Mar; 19(1):77-8. PubMed ID: 9146953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune neutropenia].
    Bux J
    Dtsch Med Wochenschr; 1996 Mar; 121(9):287. PubMed ID: 8681778
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alloimmune neonatal neutropenia. Treatment with granulocyte colony- stimulating factor].
    Cedena Romero P; Muro Brussi M; García Alonso L; Muñiz Díaz E; Cabanillas Vilaplana L; Sáez Pérez E
    An Esp Pediatr; 1996 Nov; 45(5):536-8. PubMed ID: 9036790
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia.
    Smith MA; Smith JG
    Curr Opin Hematol; 2001 May; 8(3):165-9. PubMed ID: 11303150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.
    Dale DC; Bolyard A; Marrero T; Makaryan V; Bonilla M; Link DC; Newburger P; Shimamura A; Boxer LA; Spiekerman C
    N Engl J Med; 2017 Dec; 377(23):2290-2292. PubMed ID: 29211670
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclic neutropenia with anti-NA2 antibodies and treatment with recombinant granulocyte colony-stimulating factor].
    Barrachina Barberá L; Pérez Martínez A; León García S; Pronzato Cuello F; Martín Arenós J; Toornador E
    An Pediatr (Barc); 2005 Aug; 63(2):180-2. PubMed ID: 16045884
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign lymphoproliferation syndrome, autoimmune neutropenia and thrombocytopenia in partial Di George syndrome: efficacy of rh G-CSF and prednisone.
    Martire B; Burattini MG; De Santis A; Schettini F; De Mattia D
    Acta Paediatr; 2001 Jul; 90(7):821-3. PubMed ID: 11519990
    [No Abstract]   [Full Text] [Related]  

  • 15. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute respiratory distress syndrome during neutropenia recovery.
    Azoulay E; Darmon M
    Crit Care; 2010; 14(1):114. PubMed ID: 20236481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-induced neutropenia treated with granulocyte colony-stimulating factor during home intravenous infusion therapy.
    Lai KK; Kleinjan J; Belliveau P
    Clin Infect Dis; 1996 Oct; 23(4):844-5. PubMed ID: 8909866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukemogenic risk during long-term use of G-CSF in constitutional neutropenia].
    Donadieu J
    Arch Fr Pediatr; 1993 Nov; 50(9):827. PubMed ID: 7520227
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic neutropenia and defect in superoxide generation of granulocytes in two patients: enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor.
    Káposzta R; Maródi L
    Pediatr Res; 1995 Jan; 37(1):50-5. PubMed ID: 7535420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF: a very efficient therapy in chronic autoimmune neutropenia. A brief review of the literature.
    Bauduer F
    Hematol Cell Ther; 1998 Oct; 40(5):189-91. PubMed ID: 9844813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.